Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy

被引：30
作者：
不详
机构：
来源：
GYNECOLOGIC ONCOLOGY | 2005年 / 98卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2005.05.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 181
页数：3
相关论文
共 16 条
  • [1] A genetic epidemiological study of carcinoma of the fallopian tube
    Aziz, S
    Kuperstein, G
    Rosen, B
    Cole, D
    Nedelcu, R
    McLaughlin, J
    Narod, SA
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 80 (03) : 341 - 345
  • [2] Peritoneal lavage cytology: An assessment of its value during prophylactic oophorectomy
    Colgan, TJ
    Boerner, SL
    Murphy, J
    Cole, DEC
    Narod, S
    Rosen, B
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 85 (03) : 397 - 403
  • [3] Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status
    Colgan, TJ
    Murphy, J
    Cole, DEC
    Narod, S
    Rosen, B
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) : 1283 - 1289
  • [4] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [5] Defining cancer risks for BRCA germline mutation carriers:: implications for surgical prophylaxis
    Karlan, BY
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 519 - 520
  • [6] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615
  • [7] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    [J]. SCIENCE, 2003, 302 (5645) : 643 - 646
  • [8] BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
    Lavie, O
    Hornreich, G
    Ben-Arie, A
    Rennert, G
    Cohen, Y
    Keidar, R
    Sagi, S
    Lahad, EL
    Auslander, R
    Beller, U
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 521 - 524
  • [9] Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
    Lu, KH
    Garber, JE
    Cramer, DW
    Welch, WR
    Niloff, J
    Schrag, D
    Berkowitz, RS
    Muto, MG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2728 - 2732
  • [10] Risk-reducing salpingo-oophorectomy in BRCA mutation carriers:: Role of serial sectioning in the detection of occult malignancy
    Powell, CB
    Kenley, E
    Chen, LM
    Crawford, B
    McLennan, J
    Zaloudek, C
    Komaromy, M
    Beattie, M
    Ziegler, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 127 - 132
12